skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Refined by: New Records: New From Last Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
107 deaths from covid-19 in 2023, the lowest number since the virus emerged
Material Type:
Newsletter Article
Add to My Research

107 deaths from covid-19 in 2023, the lowest number since the virus emerged

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

2
23andMe Holding (ME: 48.66c) slides 3.1% weakening below moving average price; -1.57c [3.1%]
Material Type:
Newsletter Article
Add to My Research

23andMe Holding (ME: 48.66c) slides 3.1% weakening below moving average price; -1.57c [3.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

3
23andMe Holding (ME: 50.23c) decreases; -0.23c [0.5%]
Material Type:
Newsletter Article
Add to My Research

23andMe Holding (ME: 50.23c) decreases; -0.23c [0.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

4
4 foods to lower cholesterol
Material Type:
Newsletter Article
Add to My Research

4 foods to lower cholesterol

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

5
4 foods to lower cholesterol and protect your heart
Material Type:
Newsletter Article
Add to My Research

4 foods to lower cholesterol and protect your heart

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

6
4D Molecular Therapeutics (FDMT: $26.40) rises in 4 out of last 5 days, 5-day rise of 14%; +2c [0.1%]
Material Type:
Newsletter Article
Add to My Research

4D Molecular Therapeutics (FDMT: $26.40) rises in 4 out of last 5 days, 5-day rise of 14%; +2c [0.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

7
4D Molecular Therapeutics (FDMT: $26.72) lifts 1.3% strengthening above moving average price; +34c [1.3%]
Material Type:
Newsletter Article
Add to My Research

4D Molecular Therapeutics (FDMT: $26.72) lifts 1.3% strengthening above moving average price; +34c [1.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

8
A-Fib Patients Younger Than 65 Face Heightened Risk for Heart-Related Hospitalization
Material Type:
magazinearticle
Add to My Research

A-Fib Patients Younger Than 65 Face Heightened Risk for Heart-Related Hospitalization

The clinical advisor, 2024-05

COPYRIGHT 2024 Haymarket Media, Inc. ;ISSN: 1524-7317

Full text available

9
AANP Forum
Material Type:
Article
Add to My Research

AANP Forum

Journal for nurse practitioners, 2024-05, Vol.20 (5) [Peer Reviewed Journal]

Copyright Elsevier Limited May 2024 ;ISSN: 1555-4155 ;EISSN: 1878-058X ;DOI: 10.1016/j.nurpra.2024.105017

Digital Resources/Online E-Resources

10
Acalabrutinib Plus Chemoimmunotherapy Improves PFS in Mantle Cell Lymphoma
Material Type:
Article
Add to My Research

Acalabrutinib Plus Chemoimmunotherapy Improves PFS in Mantle Cell Lymphoma

Oncology nursing news (Highland Park, N.J.), 2024-05

Copyright MultiMedia Healthcare Inc. 2024 ;ISSN: 1936-4385

Digital Resources/Online E-Resources

11
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Material Type:
Newsletter Article
Add to My Research

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

NASDAQ OMX's News Release Distribution Channel, 2024

GlobeNewswire, Inc.

Digital Resources/Online E-Resources

12
Adipose Tissue Dynamics, Thermogenesis, and Interorgan Connections for Preventing Obesity and Metabolic Disorders
Material Type:
Article
Add to My Research

Adipose Tissue Dynamics, Thermogenesis, and Interorgan Connections for Preventing Obesity and Metabolic Disorders

JMA journal, 2024-03, Vol.7 (2), p.172-177

Copyright © Japan Medical Association ;ISSN: 2433-328X ;EISSN: 2433-3298 ;DOI: 10.31662/jmaj.2023-0218

Full text available

13
Adult Medicaid dental benefits hits 5-year milestone
Material Type:
Article
Add to My Research

Adult Medicaid dental benefits hits 5-year milestone

New Hampshire Business Review, 2024-04, Vol.46 (8), p.21-21

Copyright Business Publications Inc. Apr 26-May 9, 2024 ;ISSN: 0164-8152

Full text available

14
AHN, Innovation Works AlphaLab Health Joint Venture Receives $10 Million Grant to Create Revolving Investment Fund
Material Type:
Newsletter Article
Add to My Research

AHN, Innovation Works AlphaLab Health Joint Venture Receives $10 Million Grant to Create Revolving Investment Fund

PR Newswire, 2024

Copyright PR Newswire Association LLC May 7, 2024

Digital Resources/Online E-Resources

15
Air Pollution Ups Gestational Hypertension, Mostly in Prenatal Depression Cases
Material Type:
magazinearticle
Add to My Research

Air Pollution Ups Gestational Hypertension, Mostly in Prenatal Depression Cases

The clinical advisor, 2024-05

COPYRIGHT 2024 Haymarket Media, Inc. ;ISSN: 1524-7317

Full text available

16
Allegheny Health Network's 'Art of Caring' Display Makes Stop at PNC Park for 'Healthcare Appreciation Nights'
Material Type:
Newsletter Article
Add to My Research

Allegheny Health Network's 'Art of Caring' Display Makes Stop at PNC Park for 'Healthcare Appreciation Nights'

PR Newswire, 2024

Copyright PR Newswire Association LLC May 7, 2024

Digital Resources/Online E-Resources

17
Alnylam Pharmaceuticals Applies for Patent on Compositions and Methods for Treating or Preventing Stargardt's Disease and/or Retinal Binding Protein 4 (RBP4)-Associated Disorders
Material Type:
Newsletter Article
Add to My Research

Alnylam Pharmaceuticals Applies for Patent on Compositions and Methods for Treating or Preventing Stargardt's Disease and/or Retinal Binding Protein 4 (RBP4)-Associated Disorders

Global IP News. Pharmaceutical Patent News, 2024

Copyright© 2024, Globalipnews.com

Digital Resources/Online E-Resources

18
Alzheimer's disease
Material Type:
Reports
Add to My Research

Alzheimer's disease

Mayo Clinic Health Information Library : Diseases and Conditions, 2024

2024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.

Digital Resources/Online E-Resources

19
Alzheimer's disease
Material Type:
Reports
Add to My Research

Alzheimer's disease

Mayo Clinic Health Information Library : Diseases and Conditions, 2024

2024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.

Digital Resources/Online E-Resources

20
AMA Calls Out Sick System on Chronic Conditions
Material Type:
Newsletter Article
Add to My Research

AMA Calls Out Sick System on Chronic Conditions

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Language 

  1. English  (875)
  2. Russian  (2)
  3. French  (1)
  4. Hungarian  (1)
  5. Spanish  (1)
  6. Korean  (1)
  7. Afrikaans  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait